Can Caris Life Sciences,?Inc. (CAI) Climb 32.81% to Reach the Level Wall Street Analysts Expect?

Group 1 - Caris Life Sciences, Inc. (CAI) closed at $28.86, reflecting a 12.7% gain over the past four weeks, with a mean price target of $38.33 indicating a potential upside of 32.8% [1] - The average price target among analysts ranges from a low of $28.00 to a high of $45.00, with a standard deviation of $4.72, suggesting variability in estimates [2] - Analysts show strong agreement on CAI's ability to report better earnings than previously predicted, which supports the expectation of an upside [4][11] Group 2 - The Zacks Consensus Estimate for CAI's current year earnings has increased by 7.2% over the last 30 days, with two estimates moving higher and no negative revisions [12] - CAI holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] - While the consensus price target may not be a reliable indicator of potential gains, it does provide a directional guide for price movement [14]